Generate Biomedicines
Generates novel protein therapeutics using machine learning and generative biology.
Company facts
- Founded
- 2018
- Employees
- 312
- Headquarters
- United States
- CEO
- Michael Nally
- Type
- Public
- Listed
- Nasdaq: GENB
About
Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering generative biology to create breakthrough medicines. Through The Generate Platform, we are able to expand the breadth of technical possibilities in order to fundamentally change the way medicines are made. We’ve studied millions of proteins in order to learn the generalizable rules by which nature encodes function. We can use those learned rules to generate novel medicines with specific therapeutic functions. We call this breakthrough generative biology. It represents a fundamental shift in what’s possible in the field of therapeutic development, and we are incredibly excited as we realize the breadth of its potential. The Generate Platform can generate medicines on demand across multiple therapeutic modalities with unprecedented speed and success rates. With 140k+ square feet of space in our new Boynton Yards and Andover locations, we have a collectively unstoppable team dedicated to democratizing biotherapeutics, with more joining all the time. We have already generated, built, and tested 42,000 proteins—and we’re just getting started.